Administration of a Standardized Plasma-Protein Solution (Biseko®) in High-Risk Patients With Systemic Inflammatory Response Syndrome: Influence on Cytokine Levels and Survival

Critical Care - United Kingdom
doi 10.1186/cc6449
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search